ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,086.49
0.61%
US Tech 100
20,904.00
1.11%
다우존스 지수
45,014.04
0.69%
Bitcoin
98,883.79
3.04%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Sonnet BioTherapeutics Holdings Inc (SONN) 시세

Sonnet BioTherapeutics Holdings Inc

Sonnet BioTherapeutics Holdings Inc (SONN)

NASDAQ
2.02
-0.39
(-16.18%)
종가: 05 12월 6:00AM
15분 지연
2.08
0.06
( 2.97% )
시간외 거래: 8:36AM
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
2.08
매수가
2.06
매도가
2.08
거래량
836,180
1.97 일간 변동폭 2.626
1.91 52주 범위 18.7192
market_cap
1.353M
전일 종가
2.41
개장가
2.599
최근 거래 시간
6
@
2.07
마지막 거래 시간
08:33:13
재정 규모
US$ 1,814,254
VWAP
2.1697
평균 볼륨(3m)
491,568
발행 주식
650,313
배당수익률
-
주가수익률
-0.07
주당순이익(EPS)
-28.96
매출
148k
순이익
-18.83M

Sonnet BioTherapeutics Holdings Inc 정보

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. 더 보기

섹터
Pharmaceutical Preparations
산업
Management Consulting Svcs
웹사이트
www.sonnetbio.com
본부
Wilmington, Delaware, USA
설립됨
2020
Sonnet BioTherapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker SONN. The last closing price for Sonnet BioTherapeutics was US$2.41. Over the last year, Sonnet BioTherapeutics shares have traded in a share price range of US$ 1.91 to US$ 18.7192.

Sonnet BioTherapeutics currently has 650,313 shares in issue. The market capitalisation of Sonnet BioTherapeutics is US$1.57 million. Sonnet BioTherapeutics has a price to earnings ratio (PE ratio) of -0.07.

SONN 최신 뉴스

추가 뉴스

Form 8-K - Current report

10 시간 전
Edgar (US Regulatory)

Sonnet BioTherapeutics Announces Publication Detailing the Discovery and Development of SON-1010, an Albumin-Binding IL-12 Fusion Protein, Demonstrating Its Mechanism of Action

Pankaj Mohan, CEO of Sonnet discusses what this publication means in a Virtual Investor “What This Means” segment; access here PRINCETON, NJ, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Sonnet...

10 시간 전
GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans

27 11월 2024
Edgar (US Regulatory)

Sonnet BioTherapeutics Releases Virtual Investor ‘”What this Means” Segment

Drs. Pankaj Mohan, CEO of Sonnet, and John Cini, CSO of Sonnet, discuss the Company’s recent issuance of a U.S. patent covering a variant of IL-18 incorporated into two novel immunotherapeutic...

12 11월 2024
GlobeNewswire Inc.

Form 8-K - Current report

08 11월 2024
Edgar (US Regulatory)

Form 424B4 - Prospectus [Rule 424(b)(4)]

07 11월 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

07 11월 2024
Edgar (US Regulatory)

Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules

PRINCETON, NJ, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet”) (NASDAQ: SONN), a clinical-stage company developing innovative targeted...

07 11월 2024
GlobeNewswire Inc.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

06 11월 2024
Edgar (US Regulatory)

Form 8-K - Current report

06 11월 2024
Edgar (US Regulatory)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.61-22.67657992572.692.7551.91773612.5771348CS
4-7.92-79.21010.021.9113562263.67018032CS
12-4.88-70.11494252876.9610.021.914915683.86473733CS
26-10.72-83.7512.8161.912992384.49979056CS
52-10.48-83.439490445912.5618.71921.911863546.49652763CS
156-1188.032-99.82522653331190.1121649.40161.911895735592.37699003CS
260-15324-99.986428362615326.0839916.81.9123057052601.3688809CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MIGIMawson Infrastructure Group Inc
US$ 1.10
(61.74%)
8.18M
PRFXPainReform Ltd
US$ 4.28
(59.70%)
4.36M
MTEMMolecular Templates Inc
US$ 0.41
(21.77%)
1.84M
BJDXBluejay Diagnostics Inc
US$ 4.71
(21.08%)
254.79k
VRNTVerint Systems Inc
US$ 31.35
(20.72%)
402.95k
BLUEbluebird bio Inc
US$ 0.4498
(-38.91%)
13.59M
UPXIUpexi Inc
US$ 4.50
(-24.62%)
100k
CYCNCyclerion Therapeutics Inc
US$ 5.18
(-18.43%)
1.21M
NCNOnCino Inc
US$ 36.10
(-15.06%)
318.16k
HTOOFusion Fuel Green PLC
US$ 0.447
(-14.04%)
872.75k
LCIDLucid Group Inc
US$ 2.11
(0.48%)
31.9M
BLUEbluebird bio Inc
US$ 0.4498
(-38.91%)
13.59M
PEVPhoenix Motor Inc
US$ 0.3183
(-13.60%)
9.86M
SMXSMX Security Matters Public Company
US$ 0.36
(-10.00%)
9.77M
MIGIMawson Infrastructure Group Inc
US$ 1.10
(61.74%)
8.18M

SONN Discussion

게시물 보기
tw0122 tw0122 4 주 전
Reverse split was September 
👍️0
Invest-in-America Invest-in-America 4 주 전
SONN: They announced a DUMP-to-Market routine!!! (The WORST thing any firm could do when their stock is SOARING!!!! WOW!!!!)
👍️0
Tiger Money Tiger Money 4 주 전
What is going on here?  Reverse?  Where is the float on this train wreck now?
👍️0
bigfart bigfart 4 주 전
So insiders can dump before the RS
👍️0
tw0122 tw0122 4 주 전
Reverse split offering and now some news $8s
👍️0
tw0122 tw0122 2 월 전
May the reverse split gods come soon. Keep an eye!
👍️0
BooDog BooDog 2 월 전
Another split here too.

https://www.globenewswire.com/news-release/2024/09/25/2952951/0/en/Sonnet-BioTherapeutics-Announces-1-for-8-Reverse-Stock-Split.html
👍️0
Clemdane Clemdane 3 월 전
Big jump today!
👍️0
Awl416 Awl416 4 월 전
Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiated and Funded Phase 1/2a Study of SON-1210 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer
👍️ 1
Monksdream Monksdream 4 월 전
SONN new 52=low
👍️0
Clemdane Clemdane 4 월 전
Big jump back up today. It's a very "risk on" stock so when the market is scared, everyone dumps it.
👍️0
Monksdream Monksdream 4 월 전
SONN new 52 week low
👍️0
Monksdream Monksdream 4 월 전
SONN new 52 week low
👍️0
Monksdream Monksdream 5 월 전
SONN new 52 week low
👍️0
Monksdream Monksdream 5 월 전
SONN new 52 week low
👍️0
BooDog BooDog 8 월 전
I see 76 followers here. And I have a target price of around 1.50 for support.

GL.

I do own shares and am looking for this to have a good future.
👍️0
maq1214 maq1214 9 월 전
Something must be happening behind closed doors. This stock has been ridiculously quite since the RS. Glad it’s greening again !
👍️0
81vette 81vette 9 월 전
23,198 watchers now,word is spreading like wildfire,somebody with lots of followers must be promoting this
👍️0
81vette 81vette 9 월 전
They are rare,not 1 in a million lotto rare but only a few per year maybe happen,the chart is great,how many bio pharma are bullish for 5 months straight (1 in a million lol) has accumulated also and that is very promising
👍️0
maq1214 maq1214 9 월 전
Do you think we are likely to see a merger/ partnership? I;m really hoping the reverse split last year cost me a lot
👍️0
81vette 81vette 9 월 전
$2.23 is 5 month high,next res. $5 mental,$7.57(sma200),big gaps to fill,mental 10/15/20/25 ect. lots of blue sky past 7.57,any kind of merger/buyout news could send it,thats the hype/hope/pump talk right now
👍️0
81vette 81vette 9 월 전
254k short,could squeeze with ZERO BORROW,73% fee(no rebate),5 months of accumulation= in the know are loading
👍️0
81vette 81vette 9 월 전
5 month uptrend(since r/s)accumulation,zero borrow,moving today on low vol(up13%),clinical trials different stages,float 2.78m,o/s 3m
👍️0
BooDog BooDog 9 월 전
Riding free again.
👍️0
Monksdream Monksdream 9 월 전
SONN under $2
👍️0
crowin crowin 10 월 전
Chardan Capital Maintains Buy on Sonnet BioTherapeutics, Lowers Price Target to $30
👍️0
maq1214 maq1214 10 월 전
This should get exciting soon, crazy volume yesterday !
👍️0
BooDog BooDog 10 월 전
IS it just greed or might this make good for another round trip? We'll see next week.
👍️0
BooDog BooDog 11 월 전
Good move IMO. Surprising actually.

On December 27, 2023, the Compensation Committee (the “Committee”) of the Board of Directors of Sonnet BioTherapeutics Holdings, Inc. (the “Company”) cancelled accrued but unpaid bonuses (the “Cancelled Bonuses”) that had been awarded for fiscal years 2022 and 2023 by the Committee to certain executive officers and employees of the Company. The Cancelled Bonuses total $1,930,773.10 and include (i) $631,768.12 awarded to Pankaj Mohan, Ph.D., the Company’s President and Chief Executive Officer, (ii) $312,741.79 awarded to John Cini, Ph.D, the Company’s Chief Scientific Officer and (iii) $364,504.40 awarded to Jay Cross, the Company’s Chief Financial Officer.

https://ih.advfn.com/stock-market/NASDAQ/sonnet-biotherapeutics-SONN/stock-news/92897290/form-8-k-current-report
👍️0
Monksdream Monksdream 1 년 전
SONN new 52 week low
👍️0
BooDog BooDog 1 년 전
Discount. Maybe I should have added "again". 1.60 offering and this is pushing towards the $. Very small float. Just playing the bounce. IF there is one lol.

https://www.accesswire.com/viewarticle.aspx?id=796208
👍️0
valleybenedetto valleybenedetto 1 년 전
Absolute piece of shit co, shit stock, dilution is endless. CEO should be fired. Sell now
👍️0
Monksdream Monksdream 1 년 전
SONN new 52 week low
👍️0
Monksdream Monksdream 1 년 전
SONN new 52 week low
👍️0
Monksdream Monksdream 1 년 전
SONN new 52 week low
👍️0
Monksdream Monksdream 1 년 전
SONN new 52 week low
👍️0
valleybenedetto valleybenedetto 1 년 전
If they would stop shitting on shareholders, cut costs and actually get something accomplished that would be a start.
👍️0
Monksdream Monksdream 1 년 전
If the stock continues to make new lows on its way to a delisting to Cromwell Coulson’s stock market or a dissolution I will continue to record it
👍️0
valleybenedetto valleybenedetto 1 년 전
You worry about you ok?
👍️0
Monksdream Monksdream 1 년 전
You aren’t getting any money back
Time to move on
👍️0
valleybenedetto valleybenedetto 1 년 전
Not an Urban Myth ..I've already checked. They have current D and O insurance.
👍️0
Monksdream Monksdream 1 년 전
Oh goddamn tell me another urban myth
👍️0
valleybenedetto valleybenedetto 1 년 전
They have D and O insurance. That's where you collect from. That's directors and officers insurance if you didn't know
👍️0
Monksdream Monksdream 1 년 전
You wouldn’t get anything from a class action lawsuit
Anyone connected to professional asset management abandoned this company long ago
👍️0
valleybenedetto valleybenedetto 1 년 전
CEO is awful. Nothing but offerings and RS. No meaningful news in months. Class action suit might be in order here.
👍️0
Monksdream Monksdream 1 년 전
SONN new 52 week low
👍️0
Golden Cross Golden Cross 1 년 전
Might be a short play here now
👍️0
Golden Cross Golden Cross 1 년 전
Very true.....
👍️0
antman antman 1 년 전
...During his testimony, Elon Musk called short selling “a means for, in my opinion, bad people on Wall Street to steal money from small investors.”
👍️0
tw0122 tw0122 1 년 전
Biotech CEOs are mostly Wall Street whores they get compensated to short there own companies as it’s much more lucrative. They take on that toxic financing do reverse splits as part of their regular routine. Take MULN CEO for example he has no scruples or morals nor does he hide his screwing over shareholders.
As far as trading you play the post reverse splits at the right time with the low float and that is where the loot is made.
Wall Street casino.
👍️0

최근 히스토리

NASDAQ
SONN
Sonnet BioTherapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유